Skip to main content
. 2023 Feb 22;12(5):688. doi: 10.3390/cells12050688
AD Alzheimer’s disease
ACE2 Angiotensin-converting enzyme 2
Apoe4 Apolipoprotein E4
BBB Blood–brain barrier
CNS Central nervous system
CSF Cerebrospinal fluid
CXCL8 Chemokine (C-X-C motif) ligand 8
COVID-19 Coronavirus disease-2019
CRH Corticotropin-releasing hormone
DAMPs Damage-associated molecular patterns (DAMPs)
GFAP Glial fibrillary acidic protein
HK-1 Hemokinin-1
HLA Human leukocyte antigen
Iba1 Calcium-binding adapter molecule 1
IL-1β Interleukin-1 beta
LPS Lipopolysaccharide
MMCP6, 7 Mast cell proteases 6 and 7
MAP-2 Microtubule-associated protein-2
MCI Mild cognitive impairment
mtDNA Mitochondrial DNA
MS Multiple sclerosis
NGF Nerve growth factor
NfL Neurofilament light chain
NK-1 Neurokinin-1
NLGs Neuroligins
NT Neurotensin
NSAIDs Non-steroidal anti-inflammatory drugs
NF-κB Nuclear factor kappa B
NLRP3 Nucleotide-binding domain (NOD)-like receptor protein 3
PAMPs Pathogen-associated molecular patterns
PD Parkinson’s disease
PASC Post-acute sequelae of SARS-CoV-2
PTSD Post-traumatic stress disorder
S Spike
SARS-CoV-3 Severe Acute respiratory syndrome coronavirus 2
SP Substance P
TLRs Toll-like receptors
TNF Tumor necrosis factor